Literature DB >> 11722637

Notch signalling in the regulation of peripheral immunity.

G F Hoyne1, M J Dallman, B R Champion, J R Lamb.   

Abstract

Notch signalling plays a critical role in embryogenesis, influencing the differentiation and growth of a variety of cell types across the species. In the mammalian immune system, Notch signalling operates at various levels; it controls the differentiation of haematopoietic stem cells and directs the early development of the T and B-cell lineages. It is also involved in the maturation of both CD4+ and CD8+ T cells in the thymus. The biological activities of this pathway extend beyond lymphocyte ontogeny; recent evidence has shown that it also contributes to the regulation of the peripheral immune system through its ability to influence cell survival and growth. In fulfilling this function, Notch signalling appears to act in conjunction with defined immunological signals such as cytokines, T-cell antigen receptor and co-stimulatory receptor-mediated signalling. In this review we discuss the potential of the Notch signalling pathway in the maintenance of homeostasis within the immune system affecting both peripheral tolerance and the negative feedback controlling productive immunity. The therapeutic manipulation of this pathway is likely to have broad application in a range of immunologically based diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11722637     DOI: 10.1034/j.1600-065x.2001.1820118.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  14 in total

1.  Pancreatic regeneration in chronic pancreatitis requires activation of the notch signaling pathway.

Authors:  Yun Su; Peter Büchler; Amiq Gazdhar; Nathalia Giese; Howard A Reber; Oscar J Hines; Thomas Giese; Markus W Büchler; Helmut Friess
Journal:  J Gastrointest Surg       Date:  2006-11       Impact factor: 3.452

Review 2.  CD4+ regulatory cells as a potential immunotherapy.

Authors:  Zoltán Fehérvari; Shimon Sakaguchi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

Review 3.  Myelin regeneration in multiple sclerosis: targeting endogenous stem cells.

Authors:  Jeffrey K Huang; Stephen P J Fancy; Chao Zhao; David H Rowitch; Charles Ffrench-Constant; Robin J M Franklin
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

4.  Dengue virus up-regulates expression of notch ligands Dll1 and Dll4 through interferon-β signalling pathway.

Authors:  Yuye Li; Siyu Wu; Jieying Pu; Xi Huang; Ping Zhang
Journal:  Immunology       Date:  2015-01       Impact factor: 7.397

5.  Notch ligand delta-like 4 regulates development and pathogenesis of allergic airway responses by modulating IL-2 production and Th2 immunity.

Authors:  Sihyug Jang; Matthew Schaller; Aaron A Berlin; Nicholas W Lukacs
Journal:  J Immunol       Date:  2010-10-13       Impact factor: 5.422

Review 6.  Innate Immune Response to Dengue Virus: Toll-like Receptors and Antiviral Response.

Authors:  Caroline Fernandes-Santos; Elzinandes Leal de Azeredo
Journal:  Viruses       Date:  2022-05-07       Impact factor: 5.818

Review 7.  Retinoic acid in the immune system.

Authors:  Karina Pino-Lagos; Micah J Benson; Randolph J Noelle
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

Review 8.  Tregs and allergic disease.

Authors:  Douglas S Robinson; Mark Larché; Stephen R Durham
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

Review 9.  Mechanisms underlying the induction of regulatory T cells and its relevance in the adaptive immune response in parasitic infections.

Authors:  Laura Adalid-Peralta; Gladis Fragoso; Agnes Fleury; Edda Sciutto
Journal:  Int J Biol Sci       Date:  2011-11-01       Impact factor: 6.580

10.  Notch ligand Delta-like 4 regulates disease pathogenesis during respiratory viral infections by modulating Th2 cytokines.

Authors:  Matthew A Schaller; Rupak Neupane; Brian D Rudd; Steven L Kunkel; Lara E Kallal; Pamela Lincoln; John B Lowe; Yunfang Man; Nicholas W Lukacs
Journal:  J Exp Med       Date:  2007-11-06       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.